Skip to main content

Taro to acquire Alchemee From Galderma


Clinical courses


Clinical research courses

Taro to acquire Alchemee From Galderma

Galderma and Taro Pharmaceutical Industries Ltd announced they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma. The agreement between Galderma and Taro includes Alchemee’s business and assets around the world, including the Proactiv® brand.

"We are excited to add Proactiv® to Taro’s broad portfolio of prescription and over-the- counter dermatology products. We look forward to welcoming the Alchemee team into Taro    and working together to continue to make a difference to the millions of people living with acne around the world.

Galderma is the world’s largest independent dermatology company, present in approximately 100 countries. Since our inception in 1981, we have been driven by a complete dedication to dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd.

Subscribe to PharmaTutor News Alerts by Email

<< Back to Pharma News